Syndromic Surveillance of Health Effects due to Summer Sun Overexposure: Construction of an Indicator Based on Drug Sales in Pharmacies—Preliminary Study within the PRISME Project-Reference-Cited by-同舟云学术

Syndromic Surveillance of Health Effects due to Summer Sun Overexposure: Construction of an Indicator Based on Drug Sales in Pharmacies—Preliminary Study within the PRISME Project

Published:2023-07-03 Issue:13 Volume:20 Page:6287
ISSN:1660-4601
Container-title:International Journal of Environmental Research and Public Health
language:en
Short-container-title:IJERPH

Author:

Riondel Adeline¹,Simac Leslie¹^ORCID,Catelinois Olivier¹,Morlan-Salesse Carole²,Bounoure Frédéric³^ORCID,Galan Bruno⁴,Mouly Damien¹

Affiliation:

1. Santé Publique France, Regions Division, 34 000 Montpellier, France

2. The Regional Health Agency of Occitanie, 34 000 Montpellier, France

3. D2CN, UFR of Health, NORDIC Laboratory, INSERM 1239, University of Rouen, 76 128 Mont Saint Aignan, France

4. Regional Council of the Order of Pharmacists (CROP) of Occitanie,3 4 000 Montpellier, France

Abstract

Introduction: Solar radiation is classified as a known human carcinogen. In France, people frequently ask local pharmacies to dispense products for sunburns. In the PRISME project, studying this use can be a specific and sensitive way to assess these overexposures. Objective: This study aims to construct an indicator for monitoring healthcare consumption in pharmacies after overexposure to solar UV. Methods: The study, conducted between July and August 2019, covered a sample of pharmacies located in coastal communities of southern France. A list of products for sunburn was defined. When one of the products on this list was sold, the customer was asked to fill out a questionnaire to determine whether the purchase was related to UV overexposure. A positive predictive value (PPV) per active ingredient was calculated. Results: Overall, nine pharmacies participated in the study, and 288 questionnaires were collected. The majority of products purchased were for women (60.7%), for people aged 15 and over (78.1%), and for people not living in the department (68.9%). The most frequently purchased products were our trolamine-containing products which accounted for 53% of sales. With the exception of three products, all PPVs were greater than 0.8. Conclusion: The high PPV confirms the suitability of the product selection as an indicator for monitoring healthcare consumption related to solar UV overexposure. Two indicators (one sensitive and one specific) were selected to maximise the chances of identifying UV-related remedies.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Link

https://www.mdpi.com/1660-4601/20/13/6287/pdf

Reference18 articles.

1. Beck, F., and Gautier, A. (2012). Baromètre Cancer 2010, Inpes.

2. Binder Foucard, F., Belot, A., Delafosse, P., Remontet, L., Woronoff, A.S., and Bossard, N. (2013). Estimation Nationale de L’incidence et de la Mortalité par Cancer en France Entre 1980 et 2012. Etude à Partir des Registres des Cancers du Réseau Francim—Partie 1: Tumeurs Solides.

3. Jéhannin-Ligier, K., Dantony, E., Bossard, N., Molinié, F., Defossez, G., Daubisse-Marliac, L., Delafosse, P., Remontet, L., and Uhry, Z. (2017). Projection de L’incidence et de la Mortalité par Cancer en France Métropolitaine en 2017, Santé Publique France.

4. Autier, P., Boffetta, P., Boniol, M., Boyle, P., Ferlay, J., and Aurengo, A. (2007). Attributable Causes of Cancer in France in the Year 2000, IARC Press.

5. Cancer IAfRo, and IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC. No. 100D.:363.